Filing Details

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Biotech Acquisition Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) G1125A124** (CUSIP Number) January 26, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. ** Reflects the CUSIP number for the Issuers Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (the Units). The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. G1125A124 1 Names of Reporting Persons Atalaya Capital Management LP 2 Check the appropriate box if a member of a Group (see instructions) (a) [x] (b) [ ] 3 Sec Use Only 4 Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 556,875 6 Shared Voting Power 928,125 7 Sole Dispositive Power 556,875 8 Shared Dispositive Power 928,125 9 Aggregate Amount Beneficially Owned by Each Reporting Person 1,485,000 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) [] 11 Percent of class represented by amount in row (9) 6.5% 12 Type of Reporting Person (See Instructions) IA, PN CUSIP No. G1125A124 1 Names of Reporting Persons Corbin ERISA Opportunity Fund, Ltd. 2 Check the appropriate box if a member of a Group (see instructions) (a) [x] (b) [ ] 3 Sec Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 0 6 Shared Voting Power 618,750 7 Sole Dispositive Power 0 8 Shared Dispositive Power 618,750 9 Aggregate Amount Beneficially Owned by Each Reporting Person 618,750 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) [] 11 Percent of class represented by amount in row (9) 2.7% 12 Type of Reporting Person (See Instructions) PNCUSIP No. G1125A124 1 Names of Reporting Persons Corbin Capital Partners Group, LLC 2 Check the appropriate box if a member of a Group (see instructions) (a) [X] (b) [ ] 3 Sec Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 0 6 Shared Voting Power 928,125 7 Sole Dispositive Power 0 8 Shared Dispositive Power 928,125 9 Aggregate Amount Beneficially Owned by Each Reporting Person 928,125 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) [] 11 Percent of class represented by amount in row (9) 4.0% 12 Type of Reporting Person (See Instructions) OOCUSIP No. G1125A124 1 Names of Reporting Persons Corbin Capital Partners, L.P. 2 Check the appropriate box if a member of a Group (see instructions) (a) [x] (b) [ ] 3 Sec Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 0 6 Shared Voting Power 928,125 7 Sole Dispositive Power 0 8 Shared Dispositive Power 928,125 9 Aggregate Amount Beneficially Owned by Each Reporting Person 928,125 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) [] 11 Percent of class represented by amount in row (9) 4.0% 12 Type of Reporting Person (See Instructions) IA, PNItem 1(a). Name of Issuer: Biotech Acquisition Company Item 1(b). Address of Issuers Principal Executive Offices: 545 West 25th Street, 20th Floor, New York, NY 10001 Item 2(a). Name of Person Filing: This Statement is filed on behalf of the following persons (collectively, the Reporting Persons): i. Atalaya Capital Management LP (ACM); ii. Corbin ERISA Opportunity Fund, Ltd. (Corbin); iii. Corbin Capital Partners Group, LLC (CCPG); iv. Corbin Capital Partners, L.P (CCP); and v. Corbin Opportunity Fund, L.P. (COF). ACM serves as sub-advisor to Corbin and COF, and in such capacity, exercises discretionary investment authority over the Shares (as defined below) underlying Units held directly by Corbin and COF. Item 2(b). Address of Principal Business Office or, if None, Residence: The address of the principal business office of ACM is One Rockefeller Plaza, 32nd Floor, New York, NY 10020. The address of the principal business office of each of Corbin, CCPG, CCP, and COF is 590 Madison Avenue, 31st Floor, New York, NY 10022. Item 2(c). Citizenship: Each of ACM, Corbin, CCP, and COF is a Delaware limited partnership. CCPG is a Delaware limited liability company. Item 2(d). Title and Class of Securities: Class A Common Stock, par value $0.0001 per share (the Shares) Item 2(e). CUSIP Number: G1125A124 Item 3. If This Statement is Filed Pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a: (a) [] Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c); (b) [] Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c); (c) [] Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c); (d) [] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) [] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [] Group, in accordance with 240.13d-1(b)(1)(ii)(J). This Item 3 is not applicable. Item 4(a). Amount Beneficially Owned: As of the date hereof, ACM may be deemed the beneficial owner of 1,485,000 Shares underlying Units, which amount includes the (i) 618,750 Shares underlying Units beneficially owned by Corbin and (ii) 309,375 Shares underlying Units beneficially owned by COF. Each of CCPG and CCP may be deemed the beneficial owner of 928,125 Shares underlying Units. Item 4(b). Percent of Class: As of the date hereof, ACM may be deemed the beneficial owner of approximately 6.5% of Shares outstanding, which amount includes (i) the 2.7% of Shares outstanding beneficially owned by Corbin and (ii) 1.3% of Shares outstanding beneficially owned by COF. Each of CCPG and CCP may be deemed the beneficial owner of 4.0% of Shares outstanding. (These percentages are based on 23,000,000 Shares outstanding as reported in the Issuers Current Report on Form 8-K filed on January 29, 2021.) Item 4(c). Number of shares as to which such person has: ACM: (i) Sole power to vote or to direct the vote: 556,875 (ii) Shared power to vote or to direct the vote: 928,125 (iii) Sole power to dispose or to direct the disposition of: 556,875 (iv) Shared power to dispose or to direct the disposition of: 928,125 Corbin: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 618,750 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 618,750 CCPG: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 928,125 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 928,125 CCP: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 928,125 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 928,125 COF: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 309,375 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 309,375 Item 5. Ownership of Five Percent or Less of a Class. This Item 5 is not applicable. Item 6. Ownership of more than Five Percent on Behalf of Another Person. This Item 6 is not applicable. Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. This Item 7 is not applicable. Item 8. Identification and classification of members of the group. ACM, Corbin, CCPG, CCP, and COF may be deemed members of a group, as defined in Rule 13d-5 under the Act, with respect to the Shares. Such group may be deemed to beneficially own 1,485,000 Shares. Corbin, CCPG, and CCP disclaim beneficial ownership over the Shares held directly by ACM. Item 9. Notice of Dissolution of Group. Not applicable Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Atalaya Capital Management LP By: /s/ Drew Phillips Name: Drew Phillips Title: Authorized Signatory Corbin ERISA Opportunity Fund, Ltd. By: Corbin Capital Partners, L.P., its Investment Manager By: Name: Daniel Friedman Title: General Counsel Corbin Capital Partners Group, LLC By: Name: Daniel Friedman Title: Authorized Signatory Corbin Capital Partners, L.P. By: Name: Daniel Friedman Title: General Counsel Corbin Opportunity Fund, L.P. Corbin Capital Partners, L.P., its Investment Manager By: Name: Daniel Friedman Title: General Counsel SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Atalaya Capital Management LP By: Name: Drew Phillips Title: Authorized Signatory Corbin ERISA Opportunity Fund, Ltd. By: Corbin Capital Partners, L.P., its Investment Manager By: /s/ Daniel Friedman Name: Daniel Friedman Title: General Counsel Corbin Capital Partners Group, LLC By: /s/ Daniel Friedman Name: Daniel Friedman Title: Authorized Signatory Corbin Capital Partners, L.P. By: /s/ Daniel Friedman Name: Daniel Friedman Title: General Counsel Corbin Opportunity Fund, L.P. Corbin Capital Partners, L.P., its Investment Manager By: /s/ Daniel Friedman Name: Daniel Friedman Title: General Counsel EXHIBIT INDEX Ex. A Joint Filing Agreement Exhibit A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A common stock of Biotech Acquisition Company, filed February 5, 2021 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Atalaya Capital Management LP By: /s/ Drew Phillips Name: Drew Phillips Title: Authorized Signatory Corbin ERISA Opportunity Fund, Ltd. By: Corbin Capital Partners, L.P., its Investment Manager By: Name: Daniel Friedman Title: General Counsel Corbin Capital Partners Group, LLC By: Name: Daniel Friedman Title: Authorized Signatory Corbin Capital Partners, L.P. By: Name: Daniel Friedman Title: General Counsel Corbin Opportunity Fund, L.P. Corbin Capital Partners, L.P., its Investment Manager By: Name: Daniel Friedman Title: General Counsel February 5, 2021 Exhibit A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A common stock of Biotech Acquisition Company, filed February 5, 2021 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Atalaya Capital Management LP By: Name: Drew Phillips Title: Authorized Signatory Corbin ERISA Opportunity Fund, Ltd. By: Corbin Capital Partners, L.P., its Investment Manager By: /s/ Daniel Friedman Name: Daniel Friedman Title: General Counsel Corbin Capital Partners Group, LLC By: /s/ Daniel Friedman Name: Daniel Friedman Title: Authorized Signatory Corbin Capital Partners, L.P. By: /s/ Daniel Friedman Name: Daniel Friedman Title: General Counsel Corbin Opportunity Fund, L.P. Corbin Capital Partners, L.P., its Investment Manager By: /s/ Daniel Friedman Name: Daniel Friedman Title: General Counsel February 5, 2021